熱點掃描 | 資源股走強，紫金礦業漲超5%
uSMART盈立智投7月23日消息，港股三大指數盤初下挫，截至發稿，恆指跌0.82%，報27494.97點，成交額566.95億，國企指數跌0.78%，恆生科技指數大跌1.82%，港股通淨流出16.30億。資源股直線拉昇，領漲大市，截止11:01，紫金礦業、馬鞍山鋼鐵均漲超5%，中國宏橋漲超4%，重慶鋼鐵股份、鞍鋼、江銅均漲超2%。光大證券發佈研報稱，山東省粗鋼壓減力度大於前期市場預期，未來鋼鐵行業盈利水平有望大幅提升。
汽車股走強，截止11:01，長城汽車漲超5%再破頂，大和稱盈喜超預期，預計全年純利升55%；比亞迪漲超2%，近日集團在官方平臺發佈了元PLUS預告圖；廣汽漲超1%，吉利漲幅不足1%，五菱、小鵬則逆勢跌超1%，恆大汽車高開低走，現跌超5%。
券商板塊延續昨日強勢，截止11:01，魯證期貨漲超6%，東方證券、廣發證券均漲超3%，中國銀河漲超2%，招商證券、交銀國際、光大證券、海通證券均漲超1%。
大型科技股再度走低，截止11:01，嗶哩嗶哩大跌超8%，隔夜美股b站收跌近6%，瑞信下調其目標價；快手大跌超7%拖累恆科超33點，新東方跌6%，平安好醫生跌近5%，美團、華虹半導體跌超2%，小米、中芯、百度跌超1%，騰訊、京東均跌約0.6%、阿裏股價幾乎持平；ASM太平洋逆勢漲近2%，汽車之家反彈超1%。
航運股承壓，截止11:01，東方海外國際、中遠海控均跌超4%，中遠海發跌超3%，中國外運跌超2%。
體育用品股下挫，截止11:01，特步大跌近10%，連續第6日下行，較高點回調近30%，李寧跌超9%，安踏跌近5%，中國動向、波司登跌超3%。
醫藥外包概念股走弱，截止11:01，昭衍新藥跌超5%，康龍化成、維亞生物跌超4%，藥明生物、泰格醫藥跌超3%，近日藥明生物被一主要股東出售8000萬股股份套現103億港元，藥明康德、藥明巨諾等藥明系股票也先後遭拋售；金斯瑞生物科技、藥明康德均跌超2%。
個股方面，截止11:01，中國中再漲超12%，國泰君安稱，新能源業績遭忽視，鎳鈷礦產資源待重估；上海復旦再跌超14%，A股發行定價6.23元，遠低於H股現價；國美零售漲超6%，與深投資本、怡亞通訂立框架合作協議；中化化肥,漲超7%，中期淨利預增35%至55%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
